SCHEMBL3892574

SCHEMBL3892574

CCCCC(=O)CNS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEP1B Q16820 1/20 0.54
▸ ALDH1A1 P00352 4/20 0.50
▸ MMP1 P03956 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ THRB P10828 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ HTR2A P28223 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ ADRA1A P35348 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ MMP2 P08253 2/20 0.49
▸ MMP13 P45452 2/20 0.49
▸ ADAMTS4 O75173 1/20 0.49
▸ MMP14 P50281 1/20 0.49
▸ ADAMTS5 Q9UNA0 1/20 0.49
▸ HTT P42858 1/20 0.47
▸ CA1 P00915 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3887010 0.80 ALDH1A1 (0.65) MEP1BALDH1A1
SCHEMBL13296438 0.78 TSHR (0.63) ALDH1A1LMNATHRBTSHRNPSR1
SCHEMBL13314764 0.76 TSHR (0.61) ALDH1A1LMNATSHRNPSR1SMN1; SMN2
SCHEMBL3885732 0.75 MEP1B (0.52) MEP1BALDH1A1MMP1LMNATHRB
SCHEMBL27278034 0.75 MEN1 (0.59) ALDH1A1LMNATSHRNPSR1CYP3A4
SCHEMBL28677877 0.75 KDM4E (0.71) MEP1BALDH1A1MMP1LMNATSHR
SCHEMBL6850445 0.74 MEP1B (0.62) MEP1BALDH1A1MMP1LMNATSHR
SCHEMBL11883523 0.74 CA1 (0.68) ALDH1A1LMNATHRBTSHRNPSR1
1,4-Dichlorobenzene SCHEMBL27511316 0.73 ALDH1A1 (0.54) ALDH1A1LMNACYP3A4CYP2C19SMN1; SMN2
SCHEMBL6505407 0.73 ALDH1A1 (0.68) MEP1BALDH1A1MMP1TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013184-A1 SULFONAMIDE COMPOUNDS USEFUL AS EDG RECEPTOR MODULATORS AstraZeneca AB (SE) 2009-01-14 — — EP disclosed
WO-2008059238-A1 BENZENESULFONAMIDE COMPOUNDS AS EDG-1 ANTAGONISTS USEFUL IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-05-22 — — WO disclosed
WO-2007129019-A1 SULFONAMIDE COMPOUNDS USEFUL AS EDG RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-11-15 — — WO disclosed
Send feedback